Loading company…
Perceive Biotherapeutics develops gene therapies and other treatments for eye diseases.
Founded in 2020 and based in California, Perceive Biotherapeutics develops gene therapies and other treatments for ocular diseases with unmet needs. Its programs use multiple therapeutic modalities, including research into glaucoma and neuroprotective therapies. In February 2025, it raised USD 15 million in Series A funding from GV and returning investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in